Product Information
Name:Olutasidenib
Brand:Biosynth
Description:Olutasidenib is a molecule that inhibits the platelet-derived growth factor receptor alpha (PDGFRα) and is being investigated as a treatment for chronic myeloid leukemia (CML). Olutasidenib binds to PDGFRα, which prevents the activation of the receptor. This blocks the signaling that leads to tumor progression and inhibits tumor growth. Olutasidenib has been shown to be safe in phase I/II trials, with no serious adverse effects reported.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:354.79 g/mol
Formula:C18H15ClN4O2
Purity:Min. 95%
Technical inquiry about: Olutasidenib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.